Home > Rheumatology > ACR 2019 > Spotlight on Rheumatoid Arthritis > Biologics show similar activity in patients with elderly-onset RA

Biologics show similar activity in patients with elderly-onset RA

Presented By
Dr Sadao Jinno, Kobe University School of Medicine, Japan
Conference
ACR 2019
A Japanese study showed no difference in efficacy and tolerability of biologics in two different age groups [1]. “Patients with elderly-onset rheumatoid arthritis (RA) could present with higher disease activity and increased disability as compared with those with young-onset RA. Despite this, previous studies showed elderly patients receive biologics less frequently than younger individuals, suggesting patients with elderly-onset RA are potentially undertreated,” said Dr Sadao Jinno (Kobe University School of Medicine, Japan), the study’s lead author. “On the other hand, in daily practice, many elderly-onset RA patients benefit from treatment with biologics. With our study we wanted to investigate if there are differences in efficacy and safety of biologics between the 2 age groups,” said Dr Jinno. A total of 7,183 patients with RA, aged ≥18, who were enrolled in a Japanese multicentre observational registry between September 2009 and December 2017 ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on